Theme timeline

A history of ESG

Credit: Bert van Dijk/Getty images.

Powered by

More than seven decades have passed since the UN's first resolution on human rights. Since then, corporate sustainability has come a long way as organisations strive to tackle challenges around the environment, society, and governance (ESG).  

As sustainability has evolved, environmental challenges (such as climate change and carbon emissions) have been the focus, although social and governance factors have become more prominent in recent years. Corporations have realised that effective handling of ESG challenges will ensure long-term success. 

Milestones such as the Paris Agreement, the 2021 UN Climate Change Conference (COP26) in Glasgow, and the launch of the UN’s Sustainable Development Goals (SDGs) have changed the lens through which we perceive corporate profitability.  

These and other milestones in the journey of corporate ESG are listed in the timeline below.

The journey of corporate ESG

1948

The UN adopted the Universal Declaration of Human Rights.

1967

The Environmental Defence Fund was formed to pursue legal actions against environmental damage.

1969

The National Environmental Policy Act was passed in the US.

1971

Greenpeace, a non-governmental environmental organization, was founded.

1980

The Global 2000 Report to the President recognised the significance of biodiversity in the ecosystem.

1993

The first meeting of the UN Commission on Sustainable Development took place.

1999

The Dow Jones Sustainability Index was launched.

2000

The UN’s Millennium Development Goals were established.

2001

China joined the World Trade Organization (WTO).

 2002

The World Summit on Sustainable Development was held in South Africa.

2005

The Kyoto Protocol came into force. The term ‘ESG’ was coined by the UN Global Compact.

2008

The UK Climate Change Act was proposed.

2009

China overtook the US as the world’s largest emitter of greenhouse gases (GHGs).

2010

The world Business Council for Sustainable Development introduced its Vision 2050 study.

2016

The Paris Agreement was signed.

The UN launched its 17 Sustainable Development Goals (SDGs).

2017

The US pulled out of the Paris Agreement.

The UK introduced its Clean Growth Strategy and gender pay gap reporting.

2021

The COP26 climate change summit was held in Glasgow, Scotland. 

The EU Sustainable Finance Disclosure Regulation (SFDR) came into effect.

2022

The COP27 climate change summit will be held in Sharm El-Sheikh, Egypt.

2023

The implementation of the Paris Agreement by member countries will be evaluated for the first time.

2030

Deadline for signatories of the Global Methane Pledge to cut methane emissions by 30% from 2020 levels. 

Deadline for signatories possessing 90% of the world’s forests to halt and reverse forest loss.

The UK will ban the sale of new gasoline-powered vehicles.

2035

The US will ban the sale of new gasoline-powered vehicles.

2050

Deadline for Europe to become carbon neutral. 

Deadline for the US to become carbon neutral.

2060

Deadline for China to become carbon neutral.

2070

Deadline for India to become carbon neutral.

Source: GlobalData Thematic Intelligence

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

GlobalData’s Thematic Intelligence uses proprietary data, research, and analysis to provide a forward-looking perspective on the key themes that will shape the future of the world’s largest industries and the organisations within them.

Go to article: Home | Nanoparticle drug delivery research gets a boostGo to article: Editor's letterGo to article: ContentsGo to article: Mimotopes Company InsightGo to article: MimotopesGo to article: BriefingGo to article: News in NumbersGo to article: Latest NewsGo to article: Latest DealsGo to article: Project UpdatesGo to article: NiproGo to article: In DepthGo to article: Covid-19 vaccine success bolsters nanoparticle drug delivery research Go to article: eConsent in clinical trials: What’s on the horizon?Go to article: Breathing easy: How digital inhalers are changing asthma treatmentGo to article: Primate models in pharma: What the future holds Go to article: A decade on, what’s next for CAR-T therapies?Go to article: FDA’s $7bn plan for 2024: Disclose CMOs, restart Cancer MoonshotGo to article: Molnar-Institute Company InsightGo to article: Molnar-InstituteGo to article: Thematic TakeGo to article: Thematic Take: contentsGo to article: ForewordGo to article: ESG is the most important theme of this decadeGo to article: A timeline of corporate ESGGo to article: The most pressing ESG concerns for the pharma industryGo to article: Key trends impacting ESG performance in the healthcare sectorGo to article: Latest news: ESG in pharmaGo to article: Sustainable supply chains: Clinical trials in a new era of limited resourcesGo to article: Increase in DPI use could lead to decreases in greenhouse gas emissionsGo to article: Environmental sustainability innovation: Leading companies in anti-malarial compositionsGo to article: Deal activity related to ESG in the pharmaceutical industry since 2020Go to article: ESG hiring trends in the global pharmaceutical industry since 2020Go to article: ESG patent applications in the global pharmaceutical industry since 2020Go to article: Mentions of ESG in pharmaceutical industry company filings since 2020 Go to article: GlobalData Thematic IntelligenceGo to article: Pharma Sponsored SupplementsGo to article: CfPIEGo to article: ListingsGo to article: EventsGo to article: RankingsGo to article: Buyer's GuidesGo to article: Next issue